WASHINGTON, Nov. 13, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at the following upcominginvestor conferences in November 2017.
The Stifel 2017 Healthcare Conference in New York City on Tuesday, November 14, 2017. A corporate presentation
The Jefferies 2017 London Healthcare Conference in London, England on November 15-16, 2017. A corporate presentation is scheduled for Wednesday, November 15, 2017 at 11:20 a.m. Greenwich Mean Time (6:20 a.m. Eastern Time).
The 29th Annual Piper Jaffray Healthcare Conference in New York City on Wednesday, November 29, 2017. A corporate presentation is scheduled for 3:00 p.m. Eastern Time.
The corporate presentations given at the Stifel, Jefferies and Piper conferences will be available live on Vanda's corporate website, where they also will be archived for 30 days. To access the presentations, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentations.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.
Company Contact:Jim KellyExecutive Vice President and Chief Financial OfficerVanda Pharmaceuticals Inc.(202) firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2017-investor-conferences-300554532.html
SOURCE Vanda Pharmaceuticals Inc.
Subscribe to our Free Newsletters!
Blood groups are of four important groups determined by the presence or absence of specific ...
Spermatocele is a condition in which there is a blockage in the epididymal duct, resulting in semen ...
Be a blood donor and save lives for your donated blood is separated into blood products or just ...View All